4720. These outcomes suggest that elevated levels of circulating insulin in melanoma
4720. These benefits suggest that elevated levels of circulating insulin in melanoma individuals, for example those with obesity and sort II diabetes, may perhaps compromise their responses to traditional chemotherapeutic…